Arcturus Therapeutics Q3 EPS $(0.26) Beats $(0.68) Estimate, Sales $18.297M Beat $7.998M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.68) by 61.76 percent. This is a 46.94 percent increase over losses of $(0.49) per share
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.68) by 61.76 percent. This is a 46.94 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $18.297 million which beat the analyst consensus estimate of $7.998 million by 128.77 percent. This is a 6.68 percent increase over sales of $17.151 million the same period last year.